The pharmaceutical industry is rapidly evolving, with increasing demand for high-quality Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, stands as copyrightple of this trend. To address this demand, US-based manufacturing services are gaining traction. These organizati